These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37652264)

  • 1. Microbiome and metabolome dysbiosis analysis in impaired glucose tolerance for the prediction of progression to diabetes mellitus.
    Zhang B; Zhang X; Luo Z; Ren J; Yu X; Zhao H; Wang Y; Zhang W; Tian W; Wei X; Ding Q; Yang H; Jin Z; Tong X; Wang J; Zhao L
    J Genet Genomics; 2024 Jan; 51(1):75-86. PubMed ID: 37652264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
    Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
    J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota intervenes in glucose tolerance and inflammation by regulating the biosynthesis of taurodeoxycholic acid and carnosine.
    Zhen J; Zhang Y; Li Y; Zhou Y; Cai Y; Huang G; Xu A
    Front Cell Infect Microbiol; 2024; 14():1423662. PubMed ID: 39206042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-based prediction for the transition from normal glucose tolerance (NGT) to impaired glucose tolerance (IGT) in a remote island cohort study.
    Uema T; Tsukita M; Okamoto S; Uehara M; Honma KI; Nakayama Y; Tamaki A; Miyazato M; Ashikari A; Maeda S; Imamura M; Matsushita M; Nakamura K; Masuzaki H
    Diabetes Res Clin Pract; 2024 Jul; 213():111747. PubMed ID: 38878868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical diabetes confirmed by 75-g OGTT influence on the prognosis of decompensated cirrhosis.
    Kang SH; Kim MY; Han SK; Baik SK
    J Gastroenterol Hepatol; 2024 Jan; 39(1):172-179. PubMed ID: 37697655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel test for IGT utilizing metabolite markers of glucose tolerance.
    Cobb J; Eckhart A; Perichon R; Wulff J; Mitchell M; Adam KP; Wolfert R; Button E; Lawton K; Elverson R; Carr B; Sinnott M; Ferrannini E
    J Diabetes Sci Technol; 2015 Jan; 9(1):69-76. PubMed ID: 25261439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of factors associated with changes in the oral glucose tolerance test, regardless of the values of fasting glucose].
    Lauria MW; Dias IN; Soares MM; Cordeiro GV; Barbosa VE; Ramos AV
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):708-13. PubMed ID: 22231974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
    Zhang XJ; Xiao Z; Yu HL; Zhang XX; Cheng Z; Tian HM
    Arch Med Res; 2013 Aug; 44(6):437-43. PubMed ID: 23973197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies.
    Hirabayashi K; Nakazawa Y; Matsuura H; Hara Y; Kurata T; Hirabayashi K; Saito S; Yoshikawa K; Tanaka M; Yanagisawa R; Sakashita K; Koike K
    Int J Hematol; 2014 Apr; 99(4):477-86. PubMed ID: 24557711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.
    Khaleeli AA; Johnson JN; Taylor WH
    Diabetes Metab Res Rev; 2007 Jan; 23(1):43-8. PubMed ID: 16703622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus.
    Ren Y; Hao L; Liu J; Wang P; Ding Q; Chen C; Song Y
    mSystems; 2023 Apr; 8(2):e0114622. PubMed ID: 36853013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance.
    Wildberg C; Masuch A; Budde K; Kastenmüller G; Artati A; Rathmann W; Adamski J; Kocher T; Völzke H; Nauck M; Friedrich N; Pietzner M
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6357-6370. PubMed ID: 31390012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative metagenomic and metabolomic analyses reveal gut microbiota-derived multiple hits connected to development of gestational diabetes mellitus in humans.
    Ye D; Huang J; Wu J; Xie K; Gao X; Yan K; Zhang P; Tao Y; Li Y; Zang S; Rong X; Li J; Guo J
    Gut Microbes; 2023; 15(1):2154552. PubMed ID: 36550785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.